UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 450

Sortiert nach

Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2023-05, Vol.41 (13), p.2382-2393

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

The lancet oncology, 2017, Vol.18 (1), p.63-74

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4148-4154

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333

Journal of clinical oncology, 2020-04, Vol.38 (11), p.1175-1185

2020

Link zum Volltext

Verfügbarkeit prüfen

Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431

The lancet oncology, 2022-05, Vol.23 (5), p.570-572

2022

Link zum Volltext

Verfügbarkeit prüfen

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Journal of clinical oncology, 2008-02, Vol.26 (4), p.633-638

2008

Link zum Volltext

Verfügbarkeit prüfen

Complete Surgical Resection Is Curative for Children With Hepatoblastoma With Pure Fetal Histology: A Report From the Children's Oncology Group

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3301-3306

2011

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2279-2287

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study

Journal of clinical oncology, 2019-12, Vol.37 (35), p.3369-3376

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3031-3038

2016

Link zum Volltext

Verfügbarkeit prüfen

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model

European journal of cancer (1990), 2016-01, Vol.52, p.92-101

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-01, Vol.30 (3), p.256-262

2012

Link zum Volltext

Verfügbarkeit prüfen

Upfront window vincristine/irinotecan treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee

Cancer, 2017-06, Vol.123 (12), p.2360-2367

2017

Link zum Volltext

Verfügbarkeit prüfen

Explicit underdose control based on toxicity: Four points to consider

Statistics in medicine, 2022-11, Vol.41 (27), p.5491-5493

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (10), p.1442-1450

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group

PloS one, 2014-08, Vol.9 (8), p.e104378

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report

Journal of clinical oncology, 2021-12, Vol.39 (36), p.4029-4038

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Children with Well-Differentiated Fetal Hepatoblastoma Treated with Surgery Only: Report from Children's Oncology Group Trial, AHEP0731

Journal of pediatric surgery, 2022-10, Vol.57 (10), p.251-256

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

Pediatric blood & cancer, 2015-03, Vol.62 (3), p.440-444

2015

Link zum Volltext

Verfügbarkeit prüfen

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

British journal of cancer, 2018-08, Vol.119 (5), p.615-621

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol

Journal of clinical oncology, 2021-08, Vol.39 (22), p.2463-2473

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcome for Adolescent and Young Adult Patients With Osteosarcoma: A Report From the Children's Oncology Group

Cancer, 2012-09, Vol.118 (18), p.4597-4605

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2545-2551

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 450

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(438)
Mit Volltextzugriff
(436)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(287)
Life Sciences & Biomedicine
(285)
Humans
(280)
Oncology
(249)
Child
(238)
Female
(213)
Adolescent
(205)
Male
(201)
Child, Preschool
(179)
Adult
(130)
Infant
(126)
Biological And Medical Sciences
(124)
Medical Sciences
(124)
Pediatrics
(99)
Tumors
(99)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(77)
Hematology
(65)
Chemotherapy
(64)
Treatment Outcome
(62)
Young Adult
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333

Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431

Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Complete Surgical Resection Is Curative for Children With Hepatoblastoma With Pure Fetal Histology: A Report From the Children's Oncology Group

Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study

Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group

Upfront window vincristine/irinotecan treatment of high‐risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee

Explicit underdose control based on toxicity: Four points to consider

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report

Outcomes of Children with Well-Differentiated Fetal Hepatoblastoma Treated with Surgery Only: Report from Children's Oncology Group Trial, AHEP0731

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group

Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol

Outcome for Adolescent and Young Adult Patients With Osteosarcoma: A Report From the Children's Oncology Group

Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

Suchergebnisse filtern